tiprankstipranks
Advertisement
Advertisement

XTLB Stock Latest News

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
Company AnnouncementsXTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
4d ago
XTLB
3 Penny Stocks to Watch Now, 4/30/26
PremiumMarket News
3 Penny Stocks to Watch Now, 4/30/26
4d ago
AKAN
RDAC
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
PremiumCompany Announcements
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
5d ago
6K
XTLB
XTL Biopharmaceuticals to acquire Psyga Bio
PremiumThe Fly
XTL Biopharmaceuticals to acquire Psyga Bio
5d ago
XTLB
XTL Biopharmaceuticals trading halted, news pending
PremiumThe Fly
XTL Biopharmaceuticals trading halted, news pending
1M ago
XTLB
Upcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (March 23 to March 27) – Stay Invested
1M ago
AZI
JFB
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
Premium
Company Announcements
XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026
2M ago
6K
XTLB
XTL Biopharmaceuticals announces ADS ratio change
Premium
The Fly
XTL Biopharmaceuticals announces ADS ratio change
2M ago
XTLB
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
PremiumCompany Announcements
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
2M ago
6K
XTLB
Beyond Air announces termination of NeuroNOS agreement with XTL
PremiumThe Fly
Beyond Air announces termination of NeuroNOS agreement with XTL
2M ago
XAIR
XTLB
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
PremiumCompany Announcements
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination
2M ago
6K
XTLB
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
PremiumThe Fly
XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing
2M ago
XTLB
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
PremiumCompany AnnouncementsXTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement
2M ago
6K
XTLB
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
Premium
Company Announcements
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling
2M ago
6K
XTLB
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
Premium
Company Announcements
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum
3M ago
6K
XTLB
XTL Biopharmaceuticals provides update on recent developments
PremiumThe Fly
XTL Biopharmaceuticals provides update on recent developments
3M ago
XAIR
XTLB
XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency
PremiumCompany Announcements
XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency
3M ago
6K
XTLB
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure
PremiumCompany Announcements
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure
3M ago
6K
XTLB
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance
PremiumCompany Announcements
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance
3M ago
6K
XTLB
XTL Biopharmaceuticals Calls February 17 Extraordinary Meeting to Expand Share Capital and Approve NeuroNOS-Linked Financing
PremiumCompany AnnouncementsXTL Biopharmaceuticals Calls February 17 Extraordinary Meeting to Expand Share Capital and Approve NeuroNOS-Linked Financing
4M ago
6K
XTLB
Why Is Beyond Air Stock (XAIR) Up Today?
Premium
Market News
Why Is Beyond Air Stock (XAIR) Up Today?
4M ago
XAIR
XTLB
XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement
Premium
Company Announcements
XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement
4M ago
6K
XTLB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >